Phase I trial: PI3Kα inhibitor BYL719 plus aromatase inhibitor (AI) for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC) Meeting Abstract


Authors: Shah, P. D.; Moynahan, M. E.; Modi, S.; Caravella, B. A.; Datko, F. M.; Zamora, S.; Comen, E.; Gilewski, T.; Sugarman, S. M.; D'Andrea, G.; Lake, D. E.; Goldfarb, S. B.; Patil, S.; Covey, A.; Berger, M. F.; Lacouture, M. E.; Norton, L.; Hudis, C. A.; Baselga, J.; Chandarlapaty, S.; Dickler, M. N.
Abstract Title: Phase I trial: PI3Kα inhibitor BYL719 plus aromatase inhibitor (AI) for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
Meeting Title: 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 75
Issue: 9 Suppl.
Meeting Dates: 2014 Dec 9-13
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2015-05-01
Language: English
ACCESSION: WOS:000356730200167
DOI: 10.1158/1538-7445.sabcs14-pd5-3
PROVIDER: wos
Notes: Meeting Abstract -- 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium -- DEC 09-13, 2014 -- San Antonio, TX -- S -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Sujata Patil
    462 Patil
  2. Mario E Lacouture
    340 Lacouture
  3. Mary Ellen Moynahan
    104 Moynahan
  4. Clifford Hudis
    894 Hudis
  5. Larry Norton
    674 Norton
  6. Diana E Lake
    79 Lake
  7. Maura N Dickler
    258 Dickler
  8. Anne Covey
    138 Covey
  9. Elizabeth Comen
    57 Comen
  10. Shanu Modi
    177 Modi
  11. Shari Goldfarb
    107 Goldfarb
  12. Michael Forman Berger
    531 Berger
  13. Payal Deepak Shah
    15 Shah
  14. Jose T Baselga
    476 Baselga
  15. Stephen James Zamora
    7 Zamora
Related MSK Work